TFBS Bioscience Inc.
TFBS Bioscience Inc., a contract research organization, provides biological testing services in Taiwan. It offers viral vector manufacturing services for cell and gene therapy products; and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products. The company was incorporated in 2016 and is headquartered in New Taipei City, Taiwan.
TFBS Bioscience Inc. (6939) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.012x
Based on the latest financial reports, TFBS Bioscience Inc. (6939) has a cash flow conversion efficiency ratio of -0.012x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-14.77 Million) by net assets (NT$1.19 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
TFBS Bioscience Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how TFBS Bioscience Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
TFBS Bioscience Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TFBS Bioscience Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BKK LIFE ASSUR NVDR
MU:XBLA
|
N/A |
|
VINAFREIGHT
VN:VNF
|
N/A |
|
Psyence Biomedical Ltd. Warrant
NASDAQ:PBMWW
|
0.000x |
|
238170
KO:238170
|
N/A |
|
MAD
WAR:MAD
|
N/A |
|
227420
KO:227420
|
N/A |
|
SINOTRANS -H-
MU:SIY
|
N/A |
|
Kooth plc
LSE:KOO
|
-0.136x |
Annual Cash Flow Conversion Efficiency for TFBS Bioscience Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of TFBS Bioscience Inc. from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.23 Billion | NT$28.82 Million | 0.023x | -19.31% |
| 2023-12-31 | NT$1.26 Billion | NT$36.53 Million | 0.029x | -54.46% |
| 2022-12-31 | NT$1.24 Billion | NT$78.72 Million | 0.064x | +28.59% |
| 2021-12-31 | NT$424.86 Million | NT$21.02 Million | 0.049x | -58.34% |
| 2020-12-31 | NT$247.95 Million | NT$29.45 Million | 0.119x | -- |